Exact Mass: 528.0784

Exact Mass Matches: 528.0784

Found 13 metabolites which its exact mass value is equals to given mass value 528.0784, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CHLOROCYCLINONE C

CHLOROCYCLINONE C

C26H21ClO10 (528.0823)


   

nickel(2+),1-[[6-[(2-oxidonaphthalen-1-yl)methylideneamino]-2-oxo-1,3-dihydrobenzimidazol-5-yl]iminomethyl]naphthalen-2-olate

nickel(2+),1-[[6-[(2-oxidonaphthalen-1-yl)methylideneamino]-2-oxo-1,3-dihydrobenzimidazol-5-yl]iminomethyl]naphthalen-2-olate

C29H18N4NiO3 (528.0732)


   

dTDP-3-amino-4-dehydro-2,3,6-trideoxy-alpha-D-glucose

dTDP-3-amino-4-dehydro-2,3,6-trideoxy-alpha-D-glucose

C16H24N3O13P2- (528.0784)


   

dTDP-3-amino-4-dehydro-2,3,6-trideoxy-beta-L-glucose

dTDP-3-amino-4-dehydro-2,3,6-trideoxy-beta-L-glucose

C16H24N3O13P2- (528.0784)


   

3-[[2-(4-Bromophenyl)-1-oxoethyl]amino]-3-[4-[(4-fluorophenyl)methylamino]-3-nitrophenyl]propanamide

3-[[2-(4-Bromophenyl)-1-oxoethyl]amino]-3-[4-[(4-fluorophenyl)methylamino]-3-nitrophenyl]propanamide

C24H22BrFN4O4 (528.0808)


   

N-[[(4S,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-fluoro-N-methylbenzamide

N-[[(4S,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-fluoro-N-methylbenzamide

C22H26BrFN2O5S (528.073)


   

N-[[(4R,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-fluoro-N-methylbenzamide

N-[[(4R,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-fluoro-N-methylbenzamide

C22H26BrFN2O5S (528.073)


   

3-Carboxy-1-hydroxypropylthiamine diphosphate

3-Carboxy-1-hydroxypropylthiamine diphosphate

C16H26N4O10P2S (528.0845)


A 1,3-thiazolium cation that is 1,3-thiazol-3-ium substituted by a methyl group at position 4, a (4-amino-2-methylpyrimidin-5-yl)methyl group at position 3, a 3-carboxy-1-hydroxypropyl at position 2 and a 2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl group at position 5.

   

KRAS G12C inhibitor 19

KRAS G12C inhibitor 19

C25H19ClF2N4O3S (528.0834)


KRAS G12C inhibitor 19 is a potent inhibitor of KRAS G12C. KRAS G12C inhibitor 19 significantly inhibits tumor growth (extracted from patent WO2021118877A1)[1].

   

10,20-dichloro-3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

10,20-dichloro-3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

C27H22Cl2O7 (528.0743)


   

methyl 2-chloro-6,8-dihydroxy-9-[(1s)-1-[(2-hydroxyacetyl)oxy]ethyl]-1-methoxy-3-methyl-7,12-dioxotetraphene-10-carboxylate

methyl 2-chloro-6,8-dihydroxy-9-[(1s)-1-[(2-hydroxyacetyl)oxy]ethyl]-1-methoxy-3-methyl-7,12-dioxotetraphene-10-carboxylate

C26H21ClO10 (528.0823)


   

methyl 2-chloro-6,8-dihydroxy-9-{1-[(2-hydroxyacetyl)oxy]ethyl}-1-methoxy-3-methyl-7,12-dioxotetraphene-10-carboxylate

methyl 2-chloro-6,8-dihydroxy-9-{1-[(2-hydroxyacetyl)oxy]ethyl}-1-methoxy-3-methyl-7,12-dioxotetraphene-10-carboxylate

C26H21ClO10 (528.0823)


   

(17r)-8,20-dichloro-3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6(11),7,9,14,19(24),20,22-nonaen-5-one

(17r)-8,20-dichloro-3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6(11),7,9,14,19(24),20,22-nonaen-5-one

C27H22Cl2O7 (528.0743)